Log In
Print this Print this

CYP0150, RLI15

  Manage Alerts
Collapse Summary General Information
Company Cytune Pharma S.A.S.
DescriptionFusion protein of IL-15 and IL-15 receptor alpha (IL-15RA)
Molecular Target Interleukin-15 (IL-15) ; Interleukin-15 (IL-15) receptor alpha chain (IL-15RA)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today